Customers or Patients? What Happens When Doctors See Markets Not People
This week marks a year since Miriam Zoll and I authored The New York Times op-ed “Selling the Fantasy of Fertility.” The piece, which has since been nominated for a 2014 EMMA Exceptional Merit in...
View ArticleWhen Did Normal Aging Become an Infertility Condition?
Come again? Did I read that wrong? Hasn’t aging always been synonymous with losing fertility? Menopause, anyone? Seems odd to call out normal aging as though it’s a disease or a condition that needs to...
View ArticleWorlds Collide (In a Good Way)
There are pros and cons to having two personas. For my entire career in the auto and tech worlds my business cards and email signatures have read Pamela Mahoney. I’m rather attached to my given name...
View ArticleWIRED Reframes Egg Freezing Debate
Egg freezing inadvertently gave birth to a much bigger set of conversations. It began when the business and technology press turned its sights on the topic prompted by news from Apple and Facebook....
View ArticleBioethicists in U.S. and Australia Call for Fertility Industry Regulation,...
When a former member of the ethics committee for the American Society of Reproductive Medicine (ASRM) calls for fertility industry regulation we should sit up and pay attention. Earlier this month...
View Article
